Senores Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	3,983	2,145	353.37	141.7
Revenue Growth (YoY)	85.64%	507.08%	149.38%	-
Cost of Revenue	1,807	1,089	127.96	80.75
Gross Profit	2,176	1,057	225.41	60.95
Selling, General & Admin	603.7	363.05	51.75	28.92
Other Operating Expenses	674.8	277.4	46.93	12.51
Operating Expenses	1,447	740.63	116.47	48.48
Operating Income	728.6	316.07	108.94	12.47
Interest Expense	-215.5	-85	-18.37	-5.1
Interest & Investment Income	-	4.59	0.39	1.93
Currency Exchange Gain (Loss)	-	10.71	34.21	2.68
Other Non Operating Income (Expenses)	192.6	3.42	-0.77	-0.55
EBT Excluding Unusual Items	705.7	249.79	124.4	11.43
Gain (Loss) on Sale of Assets	-	-0.35	-0.03	-
Pretax Income	705.7	249.44	124.37	11.43
Income Tax Expense	122.3	-77.64	40.04	1.52
Earnings From Continuing Operations	583.4	327.08	84.33	9.91
Minority Interest in Earnings	2.2	-12.53	-	-
Net Income	585.6	314.55	84.33	9.91
Net Income to Common	585.6	314.55	84.33	9.91
Net Income Growth	86.17%	273.00%	750.96%	-
Shares Outstanding (Basic)	36	23	10	5
Shares Outstanding (Diluted)	36	26	13	5
Shares Change (YoY)	40.98%	103.16%	131.33%	-
EPS (Basic)	16.12	13.67	8.87	1.81
EPS (Diluted)	16.12	12.21	6.65	1.81
EPS Growth	32.02%	83.61%	267.92%	-
Free Cash Flow	-2,034	-716.96	-483.56	-211.29
Free Cash Flow Per Share	-56.00	-27.82	-38.12	-38.53
Gross Margin	54.63%	49.26%	63.79%	43.01%
Operating Margin	18.30%	14.73%	30.83%	8.80%
Profit Margin	14.70%	14.66%	23.86%	6.99%
Free Cash Flow Margin	-51.08%	-33.42%	-136.84%	-149.11%
EBITDA	897	379.72	109.55	12.61
EBITDA Margin	22.52%	17.70%	31.00%	8.90%
D&A For EBITDA	168.4	63.65	0.61	0.14
EBIT	728.6	316.07	108.94	12.47
EBIT Margin	18.30%	14.73%	30.83%	8.80%
Effective Tax Rate	17.33%	-	32.19%	13.30%
Revenue as Reported	4,175	2,173	390.21	146.31
Advertising Expenses	-	8.49	3.82	0.31

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.